Effects of erythromycin on experimental extrinsic allergic alveolitis - MIYAJIMA, M; SUGA, M; NAKAGAWA, K; ITO, K; ANDO, M (Clinical and experimental allergy, 1999)
Keywords: Alveolitis, Extrinsic Allergic - drug therapy; Alveolitis, Extrinsic Allergic - metabolism; Alveolitis, Extrinsic Allergic - microbiology; animal model; Animals; Anti-Bacterial Agents - therapeutic use; Antibiotics. Antiinfectious agents. Antiparasitic agents; Arthus reaction; Arthus Reaction - prevention & control; Biological and medical sciences; Bronchoalveolar Lavage Fluid; Chemokines, CC; Chemotaxis, Leukocyte - drug effects; Cytokines - metabolism; Disease Models, Animal; erythromycin; Erythromycin - therapeutic use; extrinsic allergic alveolitis; Female; hypersensitivity pneumonitis; Immunoenzyme Techniques; intercellular adhesion molecule-1 (ICAM-1); Intercellular Adhesion Molecule-1 - metabolism; Lung - drug effects; Lung - metabolism; Lung - pathology; Macrophage Inflammatory Proteins; Medical sciences; Mice; Mice, Inbred C57BL; Miscellaneous. Antibiotics with multiple activities; Neutrophils - drug effects; Peroxidase - metabolism; Pharmacology. Drug treatments; Specific Pathogen-Free Organisms; summer-type hypersensitivity pneumonitis; Trichosporon; Trichosporon mucoides; Immunopathology; Lung disease; Allergy; Animal model; Arthus phenomenon(reaction); Intercellular adhesion molecule 1; Respiratory disease; Rodentia; Antiinflammatory agent; Erythromycin; Macrolide; Biological activity; Vertebrata; Antibiotic; Chemotherapy; Mammalia; Treatment; Mouse; Animal; Interstitial pneumonitis; Antibacterial agent; Mechanism of action